Navigation Links
Orcrist Bio Inc. Receives Approval from European Competent Authority to Initiate its Planned Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750
Date:4/6/2009

CALGARY, April 6 /PRNewswire/ - Orcrist Bio Inc. (ORC) a biotechnology company developing stem cell-mobilizing pharmaceuticals, announced today the approval of its Phase I, open-label, single-ascending-dose, safety study of HYC750 in healthy male volunteers, by the European Competent Authority in Seville, Spain. The goal of the study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics (induction of hematopoiesis) of HYC750, a patent-protected formulation of hyaluronan. The planned study will be conducted by InPEC BV (Breda, Netherlands) at their clinical trial site in Malaga, Spain.

"The approval of our Phase I clinical trial by the European authorities is another significant accomplishment for Orcrist," said Dr. Brett Schonekess, President and CEO of Orcrist. "With this approval we are now positioned to move forward with InPEC as our clinical partner and further develop HYC750 with the goal of confirming its safety profile, and to provide for a clear illustration of its stem cell mobilization properties. Ultimately, this is a key step to further advance the development of our product as a treatment for chemotherapy-related blood cell depletion."

About Orcrist Bio Inc.

Orcrist Bio Inc. is a biotechnology company dedicated to developing and commercializing promising therapeutics for areas in which a clear market opportunity exists. ORC's lead program revolves around HYC750, a novel stem cell mobilizer compound that promotes the egress of stem cells and other blood cells from the bone marrow into the blood, from which they can be harvested and applied toward treating chemotherapy-related blood cell depletion. Orcrist is actively looking to add to its pipeline exploring the innate properties of HYC750 and its effects on stem cells, as well as through in-licensing opportunities of other products with clear market potential. ORC is located in Calgary, Alberta. The company is financed by its founder
'/>"/>

SOURCE Orcrist Bio Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750
2. CTI Receives the Second Payment of $6.5 million Associated with the Sale of Interest in Zevalin Joint Venture
3. VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
4. TorreyPines Therapeutics Receives Notice of Non-Compliance with Nasdaq Continued Listing Requirements
5. Mylans Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)
6. BioMarin Receives Notice of Allowance for Once Daily Dosing Patent for Kuvan
7. PAREXEL Receives BioSingapore Award for Best Performing CRO
8. Isolagen, Inc. Receives Notification Letter from Amex
9. NeurogesX Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
10. Dow AgroSciences Receives Approval for New Technology to Control Cotton Pests in Brazil
11. Intradigm Receives Notice of Allowance for Key RNA Interference (RNAi) Patent Covering Potent siRNA Sequence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
(Date:12/2/2009)LIBREVILLE, Gabon, December 2 , - "Bolstering Biodiversity in Africa: Everyone,s Problem and Heritage" , Coinciding with the International Year of Biodiversity, 2-3 June 2010 the,Gabonese Rep
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Libreville International Conference 2-3 June 2010 2
...search,organization, is pleased to announce that l...r for the Czech Republic, received GCPj,s "Best,Cl...remony was held in,London,s historic Gibson Hall. ...panel of judges who,reviewed his achievements in t...nical trials. The judging panel was composed of a ...
...a,leading, global full-service clinical research o...ident and Chief Financial Officer Karl,"Buzz" Bren...h Annual,Healthcare Conference at the Grand Hyatt ...ity, Sept. 10-11, 2007. Kendle,s presentation is,s...n Time. (Logo: http://www.newscom.com/cgi-bin/pr...
...d of,Pharmacy has approved a 14-module, eight-hour...ewood Pharmacy. The program was developed by the,c...Department. Upon,completion of the program, each t...rate a high level of competence in all state rules... Portability and Accountability Act,(HIPAA) regula...
Other Biology Technology:Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year 2Kendle to Present at Bear Stearns 20th Annual Healthcare Conference 2NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program 2NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program 3
(Date:12/4/2009)This release is available in German . , A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previou
(Date:12/3/2009)Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, accord
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
Breaking Biology News(10 mins):How nutrition affects healthy aging 2Lifelong memories linked to stable nerve connections 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 33SBio Inc Announces Results of Annual General Meeting 5580 1Psychiatric disorders and sexual trauma are associated with lower urinary tract symptoms 59785 1Psychiatric disorders and sexual trauma are associated with lower urinary tract symptoms 59785 2SURF CRUISE CUP 2009 59783 1SURF CRUISE CUP 2009 59783 2
...heres no doubt about it ... the platypus is one od...adaptations like webbed feet to fit its aquatic li...the platypus represents for many a patchwork of ev...g with an international consortium of scientists l... Louis, Mo., has taken this theory to an entirely ...
...onal commerce of ornamental stones has grown all o...ed solid support to the aesthetics of natural ston...on. , Marble is, undoubtedly, the ornamental ston...vilizations have architectural or sculptural works...ir historic heritage. Despite this, nowadays we ha...
...ghts: , Mechanism of action of compound found to... The findings may lead researchers to develop pot...e, amyotrophic lateral sclerosis, Huntingtons dise...nant gliomas , RICHMOND, Va. (May 9, 2008) Virg...overed how an antibiotic works to modulate the act...
Other Biology News:First analysis of platypus genome may impact disease prevention 2Development of new techniques to understand marble quality and durability 2Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain 2Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain 3
...ore tubes to 1 outflow Single-cell and patch deli...everal millisecond) solution change Very small de...on , Solid construction 360, 250 and 100 micro...ny micromanipulator Available in 4, 8, and 16 cha...
steadylite plus Reporter Gene Assay System, 100 mL from PerkinElmer
pTRI-GAPDH-Human (316 bp protected fragment) from Ambion
...nsect Medium is formuatled for the growth of insec... Insect Mediu, Unsupplemented is ideal for transfe...rosylate, and yeastolate, which can interfere with... is formulated for general growth and maintenance ...
Biology Products: